The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization
Open accessAbstract
MLL fusion proteins are oncogenic transcription factors that are associated with aggressive lymphoid and myeloid leukemias. We constructed an inducible MLL fusion, MLL-ENL-ERtm, that rendered the transcriptional and transforming properties of MLL-ENL strictly dependent on the presence of 4-hydroxy-tamoxifen. MLL-ENL-ERtm-immortalized hematopoietic cells required 4-hydroxy-tamoxifen for continuous growth and differentiated terminally upon tamoxifen withdrawal. Microarray analysis performed on these conditionally transformed cells revealed Hoxa9 and Hoxa7 as well as the Hox coregulators Meis1 and Pbx3 among the targets upregulated by MLL-ENL-ERtm. Overexpression of the Hox repressor Bmi-1 inhibited the growth-transforming activity of MLL-ENL. Moreover, the enforced expression of Hoxa9 in combination with Meis1 was sufficient to substitute for MLL-ENL-ERtm function and to maintain a state of continuous proliferation and differentiation arrest. These results suggest that MLL fusion proteins impose a reversible block on myeloid differentiation through aberrant activation of a limited set of homeobox genes and Hox coregulators that are consistently expressed in MLL-associated leukemias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yeoh, E.-J., Ross, M. E., Shurtleff, S. A., Williams, W. K., Patel, D., Mahfouz, R., Behm, F. G., Raimondi, S. C., Relling, M. V., Patel, A., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00032-6 · Cited by 1,917
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
Armstrong, S. A., Staunton, J. E., Silverman, L. B., Pieters, R., den Boer, M. L., Minden, M. D., Sallan, S. E., Lander, E. S., Golub, T. R., & Korsmeyer, S. J. (2002) · Nature Genetics · doi:10.1038/ng765 · Cited by 1,723
The roles of FLT3 in hematopoiesis and leukemia
Gilliland, D. G., & Griffin, J. D. (2002) · Blood · doi:10.1182/blood-2002-02-0492 · Cited by 1,558
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
Ferrando, A. A., Neuberg, D. S., Staunton, J., Loh, M. L., Huard, C., Raimondi, S. C., Behm, F. G., Pui, C.-H., Downing, J. R., Gilliland, D. G., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00018-1 · Cited by 1,131
MLL Targets SET Domain Methyltransferase Activity to Hox Gene Promoters
Milne, T. A., Briggs, S. D., Brock, H. W., Martin, M. E., Gibbs, D., Allis, C. D., & Hess, J. L. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00741-4 · Cited by 1,053
Self-citationTkachuk, D. C., Kohler, S., & Cleary, M. L. (1992) · Cell · doi:10.1016/0092-8674(92)90602-9 · Cited by 920
Altered Hox expression and segmental identity in Mll-mutant mice
Yu, B. D., Hess, J. L., Horning, S. E., Brown, G. A. J., & Korsmeyer, S. J. (1995) · Nature · doi:10.1038/378505a0 · Cited by 875
Self-citationGu, Y., Nakamura, T., Alder, H., Prasad, R., Canaani, O., Cimino, G., Croce, C. M., & Canaani, E. (1992) · Cell · doi:10.1016/0092-8674(92)90603-a · Cited by 824
Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., & Evan, G. I. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.10.1686 · Cited by 781
Nakamura, T., Mori, T., Tada, S., Krajewski, W., Rozovskaia, T., Wassell, R., Dubois, G., Mazo, A., Croce, C. M., & Canaani, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00740-2 · Cited by 721
Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b
Kroon, E., Krosl, J., Thorsteinsdottir, U., Baban, S., Buchberg, A. M., & Sauvageau, G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3714 · Cited by 640
Ziemin-van der Poel, S., McCabe, N. R., Gill, H. J., Espinosa, R., Patel, Y., Harden, A., Rubinelli, P., Smith, S. D., LeBeau, M. M., & Rowley, J. D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10735 · Cited by 585
Core-binding factors in haematopoiesis and leukaemia
Speck, N. A., & Gilliland, D. G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc840 · Cited by 569
Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins
Ayton, P. M., & Cleary, M. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204639 · Cited by 500
Nakamura, T., Largaespada, D. A., Lee, M. P., Johnson, L. A., Ohyashiki, K., Toyama, K., Chen, S. J., Willman, C. L., Chen, I.-M., Feinberg, A. P., et al. (1996) · Nature Genetics · doi:10.1038/ng0296-154 · Cited by 493
A trithorax–like gene is interrupted by chromosome 11q23 translocations in acute leukaemias
Djabali, M., Selleri, L., Parry, P., Bower, M., Young, B. D., & Evans, G. A. (1992) · Nature Genetics · doi:10.1038/ng1092-113 · Cited by 474
Picard, D., Salser, S. J., & Yamamoto, K. R. (1988) · Cell · doi:10.1016/0092-8674(88)90122-5 · Cited by 410
Lavau, C. (1997) · The EMBO Journal · doi:10.1093/emboj/16.14.4226 · Cited by 400
Armstrong, S. A., Kung, A. L., Mabon, M. E., Silverman, L. B., Stam, R. W., Den Boer, M. L., Pieters, R., Kersey, J. H., Sallan, S. E., Fletcher, J. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00003-5 · Cited by 398
Thorsteinsdottir, U., Mamo, A., Kroon, E., Jerome, L., Bijl, J., Lawrence, H. J., Humphries, K., & Sauvageau, G. (2002) · Blood · doi:10.1182/blood.v99.1.121 · Cited by 347
Meis1, a PBX1-Related Homeobox Gene Involved in Myeloid Leukemia in BXH-2 Mice
Moskow, J. J., Bullrich, F., Huebner, K., Daar, I. O., & Buchberg, A. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5434 · Cited by 328
Yu, B. D., Hanson, R. D., Hess, J. L., Horning, S. E., & Korsmeyer, S. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10632 · Cited by 302
Self-citationDefining Roles for HOX and MEIS1 Genes in Induction of Acute Myeloid Leukemia
Thorsteinsdottir, U., Kroon, E., Jerome, L., Blasi, F., & Sauvageau, G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.224-234.2001 · Cited by 284
MLL rearrangements in haematological malignancies: lessons from clinical and biological studies
DiMartino, J. F., & Cleary, M. L. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01439.x · Cited by 259
Defects in Yolk Sac Hematopoiesis in Mll-Null Embryos
Hess, J. L., Yu, B. D., Li, B., Hanson, R., & Korsmeyer, S. J. (1997) · Blood · doi:10.1182/blood.v90.5.1799 · Cited by 257
Self-citationMLL and CREB Bind Cooperatively to the Nuclear Coactivator CREB-Binding Protein
Ernst, P., Wang, J., Huang, M., Goodman, R. H., & Korsmeyer, S. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.7.2249-2258.2001 · Cited by 252
HOXA9 Forms Triple Complexes with PBX2 and MEIS1 in Myeloid Cells
Shen, W.-F., Rozenfeld, S., Kwong, A., Kömüves, L. G., Lawrence, H. J., & Largman, C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.3051 · Cited by 249
Rozenblatt–Rosen, O., Rozovskaia, T., Burakov, D., Sedkov, Y., Tillib, S., Blechman, J., Nakamura, T., Croce, C. M., Mazo, A., & Canaani, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4152 · Cited by 239
Growth Disturbance in Fetal Liver Hematopoiesis of Mll-Mutant Mice
Yagi, H., Deguchi, K., Aono, A., Tani, Y., Kishimoto, T., & Komori, T. (1998) · Blood · doi:10.1182/blood.v92.1.108.413k11_108_117 · Cited by 238
Hanson, R. D., Hess, J. L., Yu, B. D., Ernst, P., van Lohuizen, M., Berns, A., van der Lugt, N. M. T., Shashikant, C. S., Ruddle, F. H., Seto, M., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14372 · Cited by 236
Self-citationHsieh, J. J.-D., Ernst, P., Erdjument-Bromage, H., Tempst, P., & Korsmeyer, S. J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.186-194.2003 · Cited by 234
Zeleznik-Le, N. J., Harden, A. M., & Rowley, J. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10610 · Cited by 229
Slany, R. K., Lavau, C., & Cleary, M. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.122 · Cited by 224
Self-citationBirke, M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.4.958 · Cited by 215
Translocations of the RARα gene in acute promyelocytic leukemia
Zelent, A., Guidez, F., Melnick, A., Waxman, S., & Licht, J. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204766 · Cited by 207
Lavau, C. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4655 · Cited by 203
Dimerization of MLL fusion proteins immortalizes hematopoietic cells
Martin, M. E., Milne, T. A., Bloyer, S., Galoian, K., Shen, W., Gibbs, D., Brock, H. W., Slany, R., & Hess, J. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00214-9 · Cited by 168
Self-citationHOX and Non‐HOX Homeobox Genes in Leukemic Hematopoiesis
Owens, B. M., & Hawley, R. G. (2002) · STEM CELLS · doi:10.1634/stemcells.20-5-364 · Cited by 166
Yokoyama, A., Kitabayashi, I., Ayton, P. M., Cleary, M. L., & Ohki, M. (2002) · Blood · doi:10.1182/blood-2002-04-1015 · Cited by 162
The role of MLL in hematopoiesis and leukemia
Ernst, P., Wang, J., & Korsmeyer, S. J. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200207000-00004 · Cited by 157
The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10
DiMartino, J. F., Ayton, P. M., Chen, E. H., et al. (2002) · Blood · doi:10.1182/blood.v99.10.3780 · Cited by 137
Calvo, K. R., Sykes, D. B., Pasillas, M. P., & Kamps, M. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205516 · Cited by 120
Common mechanism for oncogenic activation of MLL by forkhead family proteins
So, C. W. E., & Cleary, M. L. (2002) · Blood · doi:10.1182/blood-2002-06-1785 · Cited by 119
So, C. W. E., & Cleary, M. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.18.6542-6552.2002 · Cited by 101
Calvo, K. R., Knoepfler, P. S., Sykes, D. B., Pasillas, M. P., & Kamps, M. P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231115398 · Cited by 95
Imamura, T., Morimoto, A., Takanashi, M., Hibi, S., Sugimoto, T., Ishii, E., & Imashuku, S. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03803.x · Cited by 82
Butler, L. H., Slany, R. K., Cui, X., Cleary, M. L., & Mason, D. Y. (1997) · Blood · doi:10.1182/blood.v89.9.3361 · Cited by 72
Self-citationMLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
Schreiner, S., Birke, M. T., García-Cuéllar, M.-P., Zilles, O., Greil, J., & Slany, R. K. (2001) · PubMed · Cited by 64
Self-citationAnalysis of the Hormone-dependent Regulation of a JunD-Estrogen Receptor Chimera
Francis, M. K., Phinney, D. G., & Ryder, K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11502 · Cited by 17
Cited by
Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9
Krivtsov, A. V., Twomey, D., Feng, Z., Stubbs, M. C., Wang, Y., Faber, J., Levine, J. E., Wang, J., Hahn, W. C., Gilliland, D. G., et al. (2006) · Nature · doi:10.1038/nature04980 · Cited by 1,513
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N 6 -Methyladenosine RNA Demethylase
Li, Z., Weng, H., Su, R., Weng, X., Zuo, Z., Li, C., Huang, H., Nachtergaele, S., Dong, L., Hu, C., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.11.017 · Cited by 1,508
Shilatifard, A. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051710-134100 · Cited by 1,091
Weng, H., Huang, H., Wu, H., Qin, X., Zhao, B. S., Dong, L., Shi, H., Skibbe, J., Shen, C., Hu, C., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2017.11.016 · Cited by 968
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Daigle, S. R., Olhava, E. J., Therkelsen, C. A., Majer, C. R., Sneeringer, C. J., Song, J., Johnston, L. D., Scott, M. P., Smith, J. J., Xiao, Y., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.009 · Cited by 923
Metadata
- Authors
- Zeisig, B. B., Milne, T., García-Cuéllar, M.-P., Schreiner, S., Martin, M.-E., Fuchs, U., Borkhardt, A., Chanda, S. K., Walker, J., Soden, R., Hess, J. L., & Slany, R. K.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2004-01-01
- Volume
- 24
- Issue
- 2
- Pages
- 617-628
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2157646587
- Cited by
- 328
- References
- 49
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.